Atıf Formatları
No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

O. Yonal Et Al. , "No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects," TURKISH JOURNAL OF GASTROENTEROLOGY , vol.25, no.6, pp.639-643, 2014

Yonal, O. Et Al. 2014. No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects. TURKISH JOURNAL OF GASTROENTEROLOGY , vol.25, no.6 , 639-643.

Yonal, O., EREN, F., YILMAZ, Y., ATUĞ, Ö., & Over, H. H., (2014). No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects. TURKISH JOURNAL OF GASTROENTEROLOGY , vol.25, no.6, 639-643.

Yonal, Oya Et Al. "No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects," TURKISH JOURNAL OF GASTROENTEROLOGY , vol.25, no.6, 639-643, 2014

Yonal, Oya Et Al. "No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects." TURKISH JOURNAL OF GASTROENTEROLOGY , vol.25, no.6, pp.639-643, 2014

Yonal, O. Et Al. (2014) . "No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects." TURKISH JOURNAL OF GASTROENTEROLOGY , vol.25, no.6, pp.639-643.

@article{article, author={Oya Yonal Et Al. }, title={No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects}, journal={TURKISH JOURNAL OF GASTROENTEROLOGY}, year=2014, pages={639-643} }